Use of a pharmaceutical composition containing Epidermal Growth Factor (EGF) for diabetic foot amputation prevention

Details for Australian Patent Application No. 2002361923 (hide)

International Classifications

Event Publications

10 April 2003 Complete Application Filed

Priority application(s): 0308/01 20.12.01 CU

2 October 2003 Application Open to Public Inspection

Published as AU-B-2002361923

7 October 2004 Amendment Made

The nature of the amendment is: Amend the name of the applicant/patentee from Centro de Ingenieria Genetica y Biotecnologia, Jorge Berlanga Acosta, Jose I Fernandez Montequin, Calixto Valdes Perez, Neobalis Franco Perez, Ingrid Rojas Constantin, Hector Santana Milian, Larissa Chacon Corvea, Gerardo E Guillen Nieto, Luis Herrera Martinez, Leonardo Canan-Haden Frias, Haydee Geronimo Perez, Jorge Sotolongo Pena to Centro de Ingeniera Genetica Y Biotecnologia.

2 February 2006 Application Accepted

Published as AU-B-2002361923

8 June 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.